Work

Proteomic methods for biomarker discovery and validation. Are we there yet?

Year: 2015
Type: editorial
Abstract: Noninvasive molecular biomarkers are becoming attractive tools to monitor disease progression, aid drug development programs and use as surrogate outcome measures in clinical trials. Cutting edge proteomic methods to assay biomarkers in body fluids have been developed in the past few years, but transitioning them to clinical practice has been slow and depends on the qualification of both the method and the biomarker.
Institution: Children's National
Language: English
Subfield: Spectroscopy
Field: Chemistry
Open Access status: bronze
OpenAlex ID: W2155145689
Cites: 17
Cited by: 36
Related to: 10